Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study

Li D, Stovall DB, Wang W, Sui G. Advances of Zinc Signaling Studies in Prostate Cancer. Int J Mol Sci. 2020;21(2).

To PK, Do MH, Cho JH, Jung C. Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics. Int J Mol Sci. 2020;21(8).

National Institutes of Health Office of Dietary Supplements. Zinc, Fact Sheet for Health Professionals 2022 [Available from: https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/.

EFSA Panel on Dietetic Products N. Allergies. Scientific opinion on dietary reference values for zinc. EFSA J. 2014;12(10):3844.

Article  Google Scholar 

Fulgoni VL 3rd, Keast DR, Bailey RL, Dwyer J. Foods, fortificants, and supplements: Where do Americans get their nutrients? J Nutr. 2011;141(10):1847–54.

Ervin RB, Kennedy-Stephenson J. Mineral intakes of elderly adult supplement and non-supplement users in the third national health and nutrition examination survey. J Nutr. 2002;132(11):3422–7.

Article  CAS  PubMed  Google Scholar 

Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary supplement use among US adults from 1999–2012. JAMA. 2016;316(14):1464–74.

Article  PubMed  PubMed Central  Google Scholar 

Li J, Li X, Gathirua-Mwangi W, Song Y. Prevalence and trends in dietary supplement use among US adults with diabetes: the National Health and Nutrition Examination Surveys, 1999–2014. BMJ Open Diabetes Res Care. 2020;8(1).

Roney N. Toxicological profile for zinc. Agency for Toxic Substances and Disease Registry; 2005.

Grebow J. Dietary supplement sales skyrocket during coronavirus pandemic 2020 [Available from: https://mdanderson.libanswers.com/faq/26219.

Aysin E, Urhan M. Dramatic increase in dietary supplement use during Covid-19. Curr Developments Nutr. 2021;5(Supplement_2):207-.

Article  Google Scholar 

Radwan H, Hasan H, Jaafar Z, Abbas N, Rashed Saif E, Al Kitbi M, et al. Diets and dietary supplements used during the COVID-19 pandemic in the United Arab Emirates: A cross-sectional survey. Saudi Pharm J. 2022;30(4):421–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

The US. Food and Drug Administration. Fraudulent Coronavirus Disease 2019 (COVID-19) Products 2022 [Available from: https://www.fda.gov/consumers/health-fraud-scams/fraudulent-coronavirus-disease-2019-covid-19-products.

Epstein MM, Kasperzyk JL, Andren O, Giovannucci EL, Wolk A, Hakansson N, et al. Dietary zinc and prostate cancer survival in a Swedish cohort. Am J Clin Nutr. 2011;93(3):586–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallus S, Foschi R, Negri E, Talamini R, Franceschi S, Montella M, et al. Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol. 2007;52(4):1052–6.

Article  CAS  PubMed  Google Scholar 

Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol. 1988;127(5):999–1012.

Article  CAS  PubMed  Google Scholar 

Andersson SO, Wolk A, Bergstrom R, Giovannucci E, Lindgren C, Baron J, et al. Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer. 1996;68(6):716–22.

Article  CAS  PubMed  Google Scholar 

Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer. 1997;76(5):678–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee MM, Wang RT, Hsing AW, Gu FL, Wang T, Spitz M. Case-control study of diet and prostate cancer in China. Cancer Causes Control. 1998;9(6):545–52.

Article  CAS  PubMed  Google Scholar 

Park SY, Wilkens LR, Morris JS, Henderson BE, Kolonel LN. Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort. Prostate. 2013;73(3):261–6.

Article  CAS  PubMed  Google Scholar 

Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW. Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate. 2002;52(4):288–96.

Article  CAS  PubMed  Google Scholar 

West DW, Slattery ML, Robison LM, French TK, Mahoney AW. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control. 1991;2(2):85–94.

Article  CAS  PubMed  Google Scholar 

Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1999;8(10):887–92.

CAS  PubMed  Google Scholar 

Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst. 2003;95(13):1004–7.

Article  CAS  PubMed  Google Scholar 

Gonzalez A, Peters U, Lampe JW, White E. Zinc intake from supplements and diet and prostate cancer. Nutr Cancer. 2009;61(2):206–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Coogan P, Palmer JR, Strom BL, Rosenberg L. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control. 2009;20(5):691–8.

Article  CAS  PubMed  Google Scholar 

Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, et al. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol. 2010;172(5):566–77.

Article  PubMed  PubMed Central  Google Scholar 

Ahmad A, Mahmoud AM, Al-Alem U, Dabbous F, Ali MM, Batai K, et al. Zinc Intake and Risk of Prostate Cancer: Case-Control Study and Meta-Analysis. Plos One. 2016;11(11).

Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135(10):1114-26; discussion 27–36.

Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr. 1999;69(2):243–9.

Article  CAS  PubMed  Google Scholar 

Kim HJ, Giovannucci E, Rosner B, Willett WC, Cho E. Longitudinal and secular trends in dietary supplement use: nurses’ health study and health professionals follow-up study, 1986–2006. J Acad Nutr Dietetics. 2014;114(3):436–43.

Article  Google Scholar 

Willett W. Nutritional epidemiology. Oxford university press; 2012.

Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140(11):1016–9.

Article  CAS  PubMed  Google Scholar 

Hurwitz LM, Agalliu I, Albanes D, Barry KH, Berndt SI, Cai Q, et al. Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research. J Natl Cancer Inst. 2021;113(6):727–34.

Article  PubMed  Google Scholar 

VanderWeele TJ, Ding P. Sensitivity Analysis in Observational Research: Introducing the E-Value. Ann Intern Med. 2017;167(4):268–74.

Article  PubMed  Google Scholar 

Mathur MB, Ding P, Riddell CA, VanderWeele TJ. Web Site and R Package for Computing E-values. Epidemiology. 2018;29(5):e45-e7.

Article  Google Scholar 

Costello LC, Feng P, Milon B, Tan M, Franklin RB. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis. 2004;7(2):111–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vartsky D, Shilstein S, Bercovich A, Huszar M, Breskin A, Chechik R, et al. Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value. J Urol. 2003;170(6 Pt 1):2258–62.

Article  CAS  PubMed  Google Scholar 

Franklin RB, Costello LC. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007;463(2):211–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Zhao H, Xu Z, Cheng X. Zinc dysregulation in cancers and its potential as a therapeutic target. Cancer Biol Med. 2020;17(3):612–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nemoto K, Kondo Y, Himeno S, Suzuki Y, Hara S, Akimoto M, et al. Modulation of telomerase activity by zinc in human prostatic and renal cancer cells. Biochem Pharmacol. 2000;59(4):401–5.

Article  CAS  PubMed  Google Scholar 

Boissier S, Ferreras M, Peyruchaud O, Magnetto S, Ebetino FH, Colombel M, et al. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res. 2000;60(11):2949–54.

CAS  PubMed  Google Scholar 

Pooi-Fong W, Sazaly A. Zinc Supplementation and Prostate Cancer. Prostate Cancer: From Bench to Bedside. 2011:423.

Johnson AR, Munoz A, Gottlieb JL, Jarrard DF. High dose zinc increases hospital admissions due to genitourinary complications. J Urol. 2007;177(2):639–43.

Article  CAS  PubMed  Google Scholar 

Wong PF, Abubakar S. Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells. Oncol Rep. 2010;23(6):1501–16.

CAS  PubMed  Google Scholar 

Prasad AS, Mukhtar H, Beck FW, Adhami VM, Siddiqui IA, Din M, et al. Dietary zinc and prostate cancer in the TRAMP mouse model. J Med Food. 2010;13(1):70–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ko YH, Woo YJ, Kim JW, Choi H, Kang SH, Lee JG, et al. High-dose dietary zinc promotes prostate intraepithelial neoplasia in a murine tumor induction model. Asian J Androl. 2010;12(2):164–70.

Article 

留言 (0)

沒有登入
gif